In February St. Bernards Medical Center is hosting the Abiomed Mobile Learning Lab, a highly interactive, facilitated learning experience brought directly to the medical center to familiarize and train staff on the Impella heart pump, one of the newest, minimally invasive heart support and recovery technologies in use today.
The Impella is manufactured by Abiomed.
Impella, the world’s smallest heart pump, is a minimally invasive heart pump that offers hemodynamic support for patients during some heart procedures – assisting the pumping function of the heart. It is approved by the United States Food and Drug Administration to provide treatment during elective, high-risk percutaneous coronary intervention procedures and in the emergent treatment of cardiogenic shock, a condition that may occur during or after a heart attack. It is the only minimally invasive heart pump that has been approved as safe and effective by the FDA for use in the U.S.
The mobile learning lab offers cardiologists, nurses and cath lab staff at St. Bernards a convenient opportunity to learn about the Impella platform and how these heart pumps best can be used for specific patients in critical need of cardiac support. The lab contains various Impella simulators, animations and key information, all presented by a team of Abiomed trainers.
St. Bernards has the largest number of heartcare physicians on its medical staff of any facility in the region. Those physicians include both interventional and non-interventional cardiologists, cardiovascular surgeons and electrophysiologists (who specialize in heart rhythm problems).
Special gueses on the day of the Mobile Lab visit were a couple of heart patients who benefited from use of the high tech device -- Teresa Rolland and Brick Waggoner.
The Impella products were developed by Abiomed Inc., based in Danvers, Mass.
Abiomed’s portfolio of heart support and recovery products and services offers healthcare professionals an array of choices across a broad clinical spectrum. More than 45,000 patients in the U.S. have benefited from Impella support.
About St. Bernards
St. Bernards is a 438-bed acute care hospital that serves at a referral center for a 23-county area in Northeast Arkansas and Southeast Missouri, caring for the sickest of the sick. It is the only Level III Trauma Center in the region and has the only Neonatal Intensive Care Unit in Eastern Arkansas. It was the only medical center in Arkansas to be recognized by the American Heart Association as a Mission: Lifeline® Receiving Center GOLD PLUS Level facility for the last two consecutive years.
The Impella products offer the unique ability to stabilize the patient’s hemodynamics and unload the heart, which allows the muscle time to rest and potentially recover its native function. The Impella 2.5 heart pump received FDA Premarket Approval for high-risk PCI in March of 2015. The Impella 2.5 , Impella CO and Impella 5.0 heart pumps received FDA Premarket Approval for treatment of cardiogenic shock following an acute myocardial infarction/heart attack or after heart surgery in April of 2016. These are the first – and only – percutaneous ventricular support devices that are FDA approved as safe and effective for the cardiogenic shock indication. The Impella product portfolio includes the Impella 2.5, Impella CPP, Impella 5.0, Impella LD and Impella RP devices.